Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial

Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial

Background Recent studies have shown improved outcomes in cardiogenic shock through protocols directed toward early identification and initiation of mechanical circulatory support. However, objective therapeutic targets—based on clinical and/or laboratory data—to guide real‐time clinical decision ma...

Full description

Bibliographic Details
Main Authors: Jeffrey A. Marbach, Pietro Di Santo, Navin K. Kapur, Katherine L. Thayer, Trevor Simard, Richard G. Jung, Simon Parlow, Omar Abdel‐Razek, Shannon M. Fernando, Marino Labinaz, Michael Froeschl, Rebecca Mathew, Benjamin Hibbert
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiogenic shock
lactate clearance
mortality
surrogate end point
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023322

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.023322

Similar Items